 |
PDBsum entry 1i3z
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1i3z
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
20:5840-5852
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
|
|
M.Morra,
J.Lu,
F.Poy,
M.Martin,
J.Sayos,
S.Calpe,
C.Gullo,
D.Howie,
S.Rietdijk,
A.Thompson,
A.J.Coyle,
C.Denny,
M.B.Yaffe,
P.Engel,
M.J.Eck,
C.Terhorst.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The T and natural killer (NK) cell-specific gene SAP (SH2D1A) encodes a 'free
SH2 domain' that binds a specific tyrosine motif in the cytoplasmic tail of SLAM
(CD150) and related cell surface proteins. Mutations in SH2D1A cause the
X-linked lymphoproliferative disease, a primary immunodeficiency. Here we report
that a second gene encoding a free SH2 domain, EAT-2, is expressed in
macrophages and B lympho cytes. The EAT-2 structure in complex with a
phosphotyrosine peptide containing a sequence motif with Tyr281 of the
cytoplasmic tail of CD150 is very similar to the structure of SH2D1A complexed
with the same peptide. This explains the high affinity of EAT-2 for the pTyr
motif in the cytoplasmic tail of CD150 but, unlike SH2D1A, EAT-2 does not bind
to non-phosphorylated CD150. EAT-2 binds to the phosphorylated receptors CD84,
CD150, CD229 and CD244, and acts as a natural inhibitor, which interferes with
the recruitment of the tyrosine phosphatase SHP-2. We conclude that EAT-2 plays
a role in controlling signal transduction through at least four receptors
expressed on the surface of professional antigen-presenting cells.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 The human EAT-2 gene. (A) Alignment of the human and
mouse EAT-2 nucleotide sequences. The coding region sequences of
the human (hEAT-2) and mouse (mEAT-2) EAT-2 cDNAs are compared.
Exon boundaries are indicated (bold font, identity of
nucleotides; regular font, difference of nucleotides). (B)
Genomic organization of the human EAT-2 gene. The human EAT-2
gene consists of four exons that present an overall organization
similar to that of the SH2D1A gene. The putative exon IIIA
represents part of exon III (see text).
|
 |
Figure 4.
Figure 4 EAT-2 binds exclusively to a phosphorylated peptide
(pY281) derived from the cytoplasmic tail of CD150. (A)
Fluorescence polarization analysis of the EAT-2 binding to a
phosphorylated pY281 peptide. Different concentrations of GST
-mouse EAT-2 (or GST -human SH2D1A) and an 11mer synthetic
peptide identical to amino acid residues 276 -287 of human CD150
(Sayos et al., 1998), tyrosine phosphorylated or not, were used.
Top panel: binding of GST -mouse EAT-2 to the pY281 (filled
triangles and continuous line) or the Y281 peptide (open squares
and dashed line). Bottom panel: binding of GST -human SH2D1A to
the pY281 (filled triangles and continuous line) or the Y281
peptide (open squares and dashed line). x-axis: protein
concentration (nM); y-axis: polarization units (mP). The table
summarizes the apparent dissociation constant (kD). (B) Hybrid
system analysis of the interaction between EAT-2 and the
cytoplasmic tail of CD150 in the presence or absence of fyn.
Dashed bars indicate the interaction between the EAT-2 (or
SH2D1A) full-length protein fused to a GAL4 DNA-binding domain
and the GAL4 DNA activation domain fused to the cytoplasmic tail
of the CD150 receptor. An empty pGAD424 vector was used as a
control (solid bars). The test was conducted in either the
presence or absence of fyn[420,531Y -F]. y-axis = -galactosidase
(U/ml).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2001,
20,
5840-5852)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Cannons,
S.G.Tangye,
and
P.L.Schwartzberg
(2011).
SLAM family receptors and SAP adaptors in immunity.
|
| |
Annu Rev Immunol,
29,
665-705.
|
 |
|
|
|
|
 |
C.Detre,
M.Keszei,
X.Romero,
G.C.Tsokos,
and
C.Terhorst
(2010).
SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
|
| |
Semin Immunopathol,
32,
157-171.
|
 |
|
|
|
|
 |
H.Furukawa,
S.Tohma,
H.Kitazawa,
H.Komori,
M.Nose,
and
M.Ono
(2010).
Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
|
| |
Arch Immunol Ther Exp (Warsz),
58,
37-44.
|
 |
|
|
|
|
 |
J.O.Wrabl,
and
V.J.Hilser
(2010).
Investigating homology between proteins using energetic profiles.
|
| |
PLoS Comput Biol,
6,
e1000722.
|
 |
|
|
|
|
 |
A.Veillette,
Z.Dong,
L.A.Pérez-Quintero,
M.C.Zhong,
and
M.E.Cruz-Munoz
(2009).
Importance and mechanism of 'switch' function of SAP family adapters.
|
| |
Immunol Rev,
232,
229-239.
|
 |
|
|
|
|
 |
N.G.Clarkson,
and
M.H.Brown
(2009).
Inhibition and activation by CD244 depends on CD2 and phospholipase C-gamma1.
|
| |
J Biol Chem,
284,
24725-24734.
|
 |
|
|
|
|
 |
I.E.Sánchez,
P.Beltrao,
F.Stricher,
J.Schymkowitz,
J.Ferkinghoff-Borg,
F.Rousseau,
and
L.Serrano
(2008).
Genome-wide prediction of SH2 domain targets using structural information and the FoldX algorithm.
|
| |
PLoS Comput Biol,
4,
e1000052.
|
 |
|
|
|
|
 |
C.S.Ma,
K.E.Nichols,
and
S.G.Tangye
(2007).
Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
|
| |
Annu Rev Immunol,
25,
337-379.
|
 |
|
|
|
|
 |
J.Sintes,
M.Vidal-Laliena,
X.Romero,
V.Tovar,
and
P.Engel
(2007).
Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family.
|
| |
Tissue Antigens,
70,
355-362.
|
 |
|
|
|
|
 |
N.G.Clarkson,
S.J.Simmonds,
M.J.Puklavec,
and
M.H.Brown
(2007).
Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase.
|
| |
J Biol Chem,
282,
25385-25394.
|
 |
|
|
|
|
 |
A.Veillette
(2006).
Immune regulation by SLAM family receptors and SAP-related adaptors.
|
| |
Nat Rev Immunol,
6,
56-66.
|
 |
|
|
|
|
 |
A.Veillette
(2006).
NK cell regulation by SLAM family receptors and SAP-related adapters.
|
| |
Immunol Rev,
214,
22-34.
|
 |
|
|
|
|
 |
A.Y.Chan,
J.M.Westcott,
J.M.Mooney,
E.K.Wakeland,
and
J.D.Schatzle
(2006).
The role of SAP and the SLAM family in autoimmunity.
|
| |
Curr Opin Immunol,
18,
656-664.
|
 |
|
|
|
|
 |
C.Gu,
S.G.Tangye,
X.Sun,
Y.Luo,
Z.Lin,
and
J.Wu
(2006).
The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
|
| |
Proc Natl Acad Sci U S A,
103,
14447-14452.
|
 |
|
|
|
|
 |
E.A.Ostrakhovitch,
and
S.S.Li
(2006).
The role of SLAM family receptors in immune cell signaling.
|
| |
Biochem Cell Biol,
84,
832-843.
|
 |
|
|
|
|
 |
I.Tassi,
J.Klesney-Tait,
and
M.Colonna
(2006).
Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
|
| |
Immunol Rev,
214,
92.
|
 |
|
|
|
|
 |
S.Calpe,
E.Erdos,
G.Liao,
N.Wang,
S.Rietdijk,
M.Simarro,
B.Scholtz,
J.Mooney,
C.H.Lee,
M.S.Shin,
E.Rajnavölgyi,
J.Schatzle,
H.C.Morse,
C.Terhorst,
and
A.Lanyi
(2006).
Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters.
|
| |
Immunogenetics,
58,
15-25.
|
 |
|
|
|
|
 |
A.Uren,
and
J.A.Toretsky
(2005).
Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
|
| |
Future Oncol,
1,
521-528.
|
 |
|
|
|
|
 |
K.E.Nichols,
C.S.Ma,
J.L.Cannons,
P.L.Schwartzberg,
and
S.G.Tangye
(2005).
Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
|
| |
Immunol Rev,
203,
180-199.
|
 |
|
|
|
|
 |
M.Colonna
(2005).
Fine-tuning NK cell responses: it's a family affair.
|
| |
Nat Immunol,
6,
961-962.
|
 |
|
|
|
|
 |
R.Roncagalli,
J.E.Taylor,
S.Zhang,
X.Shi,
R.Chen,
M.E.Cruz-Munoz,
L.Yin,
S.Latour,
and
A.Veillette
(2005).
Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.
|
| |
Nat Immunol,
6,
1002-1010.
|
 |
|
|
|
|
 |
K.M.Lee,
M.E.McNerney,
S.E.Stepp,
P.A.Mathew,
J.D.Schatzle,
M.Bennett,
and
V.Kumar
(2004).
2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
|
| |
J Exp Med,
199,
1245-1254.
|
 |
|
|
|
|
 |
S.Latour,
and
A.Veillette
(2004).
The SAP family of adaptors in immune regulation.
|
| |
Semin Immunol,
16,
409-419.
|
 |
|
|
|
|
 |
X.Romero,
D.Benítez,
S.March,
R.Vilella,
M.Miralpeix,
and
P.Engel
(2004).
Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
|
| |
Tissue Antigens,
64,
132-144.
|
 |
|
|
|
|
 |
A.Veillette,
and
S.Latour
(2003).
The SLAM family of immune-cell receptors.
|
| |
Curr Opin Immunol,
15,
277-285.
|
 |
|
|
|
|
 |
B.Chan,
A.Lanyi,
H.K.Song,
J.Griesbach,
M.Simarro-Grande,
F.Poy,
D.Howie,
J.Sumegi,
C.Terhorst,
and
M.J.Eck
(2003).
SAP couples Fyn to SLAM immune receptors.
|
| |
Nat Cell Biol,
5,
155-160.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Li,
C.Iosef,
C.Y.Jia,
V.K.Han,
and
S.S.Li
(2003).
Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors.
|
| |
J Biol Chem,
278,
3852-3859.
|
 |
|
|
|
|
 |
J.M.Del Valle,
P.Engel,
and
M.Martín
(2003).
The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2).
|
| |
J Biol Chem,
278,
17430-17437.
|
 |
|
|
|
|
 |
K.C.Gilmour,
and
H.B.Gaspar
(2003).
Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
|
| |
Expert Rev Mol Diagn,
3,
549-561.
|
 |
|
|
|
|
 |
P.Engel,
M.J.Eck,
and
C.Terhorst
(2003).
The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
|
| |
Nat Rev Immunol,
3,
813-821.
|
 |
|
|
|
|
 |
S.Ilangumaran,
and
R.Rottapel
(2003).
Regulation of cytokine receptor signaling by SOCS1.
|
| |
Immunol Rev,
192,
196-211.
|
 |
|
|
|
|
 |
S.Latour,
and
A.Veillette
(2003).
Molecular and immunological basis of X-linked lymphoproliferative disease.
|
| |
Immunol Rev,
192,
212-224.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |